Literature DB >> 4555072

Therapy of rheumatoid arthritis. A pyramidal plan.

C J Smyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4555072     DOI: 10.1080/00325481.1972.11698261

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


× No keyword cloud information.
  4 in total

1.  Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.

Authors:  Peter K Schädlich; Henning Zeidler; Angela Zink; Erika Gromnica-Ihle; Matthias Schneider; Christoph Straub; Josef G Brecht; Eduard Huppertz
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis.

Authors:  A Zink; J Listing; M Niewerth; H Zeidler
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 3.  Combination therapy with biologic agents in rheumatic diseases: current and future prospects.

Authors:  Kentaro Inui; Tatsuya Koike
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-08-29       Impact factor: 5.346

Review 4.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.